[2] Puga A，Ma C，Marlowe JL. The aryl hydrocarbon receptor crosstalks with multiple signal transduction pathways[J]. Biochem Pharmacol，2009，77(4) : 713 － 722.
[2] Costa C，Catania S，De Pasquale R，et al. Exposure of human skin to benzo[a]. pyrene: role of CYP1A1 and aryl hydrocarbon receptor in oxidative stress generation[J]. Toxicology，2010，271(3) : 83 － 86.
[3] Chang X，Fan Y，Karyala S，et al. Ligand-independent regulation of transforming growth factor 1 expression and cell cycle progression by the aryl hydrocarbon receptor[J]. Mol Cell Biol，2007，27(17) : 6127 － 6139.
[4] Putluri N，Shojaie A，Vasu VT. et al. Metabolomic profiling reveals potential markers and bioprocesses altered in bladder cancerprogression [J]. Cancer Res，2011，71(24) : 7373 － 7386.
[5] Goth-Goldstein R，Stampfer MR，Erdmann CA，et al. Interindividual variation in CYP1A1 expression in breast tissue and the role of genetic polymorphism[J]. Carcinogenesis，2000，21 (11) : 2119 －2122.
[6] Oyama T，Sugio K，Uramoto H，et al. Increased cytochrome P450 and aryl hydrocarbon receptor in bronchial epithelium of heavy smokers with non-small cell lung carcinoma carries a poor prognosis[J]. Front Biosci，2007，12: 4497 － 4503.
[7] Oyama T，Sugio K，Uramoto H. et al. Cytochrome P450 expression(CYP) in non-small cell lung cancer[J]. Front，2007，12 (1) :2299 － 2308.
[8] Yang XR，Wacholder S，Xu Z. et al. CYP1A1 and GSTM1 polymorphisms in relation to lung cancer risk in Chinese woman[J]. Cancer Lett，2004，2 14(2) : 197 － 204.
[9] Lo Nigro C，Monteverde M，Riba M，et al. Expression profiling and long lasting responses to chemotherapy in metastatic gastric cancer[J]. Int J Oncol，2010，37(5) : 1219 － 1228.
[10] Hsu CM，Hsu YA，Tsai Y. et al. Emodin inhibits the growth of hepatoma cells: finding the common anti-cancer pathway using Huh7，Hep3B，and HepG2 cells[J]. Biochem Biophys ResCommun，2010，392(4) : 473 － 478.
[11] Mohammed K，Shervington A. Can CYP1A1 siRNA be an effective treatment for lung cancer[J]. Cell Mol Biol Lett，2008，13(2) : 240 － 249.